Latest News about GLUE
Recent news which mentions GLUE
Monte Rosa Shares Rise As FDA Announced Clearance To MYC-Driven Cancer Study
September 06, 2022
Tickers
GLUE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022
August 15, 2022
From Benzinga
From Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
From Benzinga
From Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 07, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 25, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 28, 2021
From Benzinga
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
66 Biggest Movers From Friday
November 01, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
From Benzinga
54 Biggest Movers From Yesterday
September 09, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.